Sanofi-aventis and the Massachusetts Institute of Technology (MIT) Center for Biomedical Innovation have struck a strategic alliance to advance cutting-edge research and foster collaboration between academia and industry.
The Sanofi-aventis Biomedical Innovation Program (SABIP) will encourage basic and applied research and promote scientific exchange between MIT and Sanofi-aventis.
The alliance will give Sanofi-aventis the opportunity to develop any therapeutic, diagnostic and prognostic applications based on the discoveries made during the alliance.
The SABIP will support a number of activities over the next three years via Biomedical Innovation Funding Awards, which will provide MIT researchers with the support to develop innovative research projects.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData